DR REDDYS LABORATORIES
Back to Income Statement
|
DR REDDYS LABORATORIES Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹24,670 Cr | ₹21,545 Cr | ₹19,048 Cr | ₹17,517 Cr | ₹15,448 Cr |
What is the latest Revenue of DR REDDYS LABORATORIES ?
Year | Revenue |
---|---|
Mar2024 | ₹24,670 Cr |
Mar2023 | ₹21,545 Cr |
Mar2022 | ₹19,048 Cr |
Mar2021 | ₹17,517 Cr |
Mar2020 | ₹15,448 Cr |
How is Revenue of DR REDDYS LABORATORIES Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹24,670 Cr | 14.50 | |
Mar2023 | ₹21,545 Cr | 13.11 | |
Mar2022 | ₹19,048 Cr | 8.74 | |
Mar2021 | ₹17,517 Cr | 13.39 | |
Mar2020 | ₹15,448 Cr | - |
Compare Revenue of peers of DR REDDYS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DR REDDYS LABORATORIES | ₹113,613.0 Cr | 3.2% | 10.3% | 11.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,176.0 Cr | -0.3% | -2.9% | 11.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,076.0 Cr | 0.7% | 7.4% | 48.1% | Stock Analytics | |
CIPLA | ₹121,592.0 Cr | -0.1% | 0.2% | -2.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,024.0 Cr | 2.3% | -0.5% | 13.8% | Stock Analytics | |
MANKIND PHARMA | ₹98,309.9 Cr | 1.1% | -7% | 9.7% | Stock Analytics |
DR REDDYS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DR REDDYS LABORATORIES | 3.2% |
10.3% |
11.7% |
SENSEX | -1.3% |
-0.3% |
5.8% |
You may also like the below Video Courses